nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCG2—Cladribine—multiple sclerosis	0.114	0.159	CbGbCtD
Pantoprazole—ABCG2—Mitoxantrone—multiple sclerosis	0.0832	0.116	CbGbCtD
Pantoprazole—SLCO1B1—Methotrexate—multiple sclerosis	0.0436	0.0608	CbGbCtD
Pantoprazole—ABCG2—Dexamethasone—multiple sclerosis	0.0431	0.0601	CbGbCtD
Pantoprazole—ABCB1—Methylprednisolone—multiple sclerosis	0.0411	0.0573	CbGbCtD
Pantoprazole—CYP3A4—Fingolimod—multiple sclerosis	0.0382	0.0533	CbGbCtD
Pantoprazole—ABCG2—Methotrexate—multiple sclerosis	0.0346	0.0483	CbGbCtD
Pantoprazole—CYP2C19—Prednisone—multiple sclerosis	0.0309	0.043	CbGbCtD
Pantoprazole—ABCB1—Mitoxantrone—multiple sclerosis	0.03	0.0418	CbGbCtD
Pantoprazole—ABCB1—Betamethasone—multiple sclerosis	0.0267	0.0373	CbGbCtD
Pantoprazole—ABCB1—Prednisolone—multiple sclerosis	0.0264	0.0368	CbGbCtD
Pantoprazole—ABCB1—Prednisone—multiple sclerosis	0.0249	0.0347	CbGbCtD
Pantoprazole—CYP3A4—Methylprednisolone—multiple sclerosis	0.0246	0.0343	CbGbCtD
Pantoprazole—CYP2C19—Dexamethasone—multiple sclerosis	0.0193	0.0269	CbGbCtD
Pantoprazole—CYP3A4—Triamcinolone—multiple sclerosis	0.0187	0.026	CbGbCtD
Pantoprazole—CYP3A4—Mitoxantrone—multiple sclerosis	0.018	0.025	CbGbCtD
Pantoprazole—CYP2C9—Dexamethasone—multiple sclerosis	0.016	0.0223	CbGbCtD
Pantoprazole—CYP3A4—Betamethasone—multiple sclerosis	0.016	0.0223	CbGbCtD
Pantoprazole—CYP3A4—Prednisolone—multiple sclerosis	0.0158	0.022	CbGbCtD
Pantoprazole—ABCB1—Dexamethasone—multiple sclerosis	0.0155	0.0217	CbGbCtD
Pantoprazole—CYP3A4—Prednisone—multiple sclerosis	0.0149	0.0208	CbGbCtD
Pantoprazole—ABCB1—Methotrexate—multiple sclerosis	0.0125	0.0174	CbGbCtD
Pantoprazole—CYP3A4—Dexamethasone—multiple sclerosis	0.00931	0.013	CbGbCtD
Pantoprazole—SLCO1B1—Irinotecan Pathway—BCHE—multiple sclerosis	0.000321	0.032	CbGpPWpGaD
Pantoprazole—ABCG2—Irinotecan Pathway—BCHE—multiple sclerosis	0.000297	0.0296	CbGpPWpGaD
Pantoprazole—ABCG2—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00026	0.026	CbGpPWpGaD
Pantoprazole—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000206	0.0206	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transport of organic anions—ALB—multiple sclerosis	0.000183	0.0183	CbGpPWpGaD
Pantoprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000181	0.0181	CbGpPWpGaD
Pantoprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000181	0.0181	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000173	0.0173	CbGpPWpGaD
Pantoprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000169	0.0169	CbGpPWpGaD
Pantoprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000169	0.0169	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000154	0.0154	CbGpPWpGaD
Pantoprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000145	0.0144	CbGpPWpGaD
Pantoprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000145	0.0144	CbGpPWpGaD
Pantoprazole—Paraesthesia—Prednisolone—multiple sclerosis	0.00014	0.000514	CcSEcCtD
Pantoprazole—Tachycardia—Triamcinolone—multiple sclerosis	0.00014	0.000514	CcSEcCtD
Pantoprazole—Mental disorder—Prednisone—multiple sclerosis	0.00014	0.000513	CcSEcCtD
Pantoprazole—Nausea—Azathioprine—multiple sclerosis	0.00014	0.000512	CcSEcCtD
Pantoprazole—Tachycardia—Methylprednisolone—multiple sclerosis	0.00014	0.000512	CcSEcCtD
Pantoprazole—Skin disorder—Methylprednisolone—multiple sclerosis	0.000139	0.00051	CcSEcCtD
Pantoprazole—Malnutrition—Prednisone—multiple sclerosis	0.000139	0.000509	CcSEcCtD
Pantoprazole—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000139	0.000509	CcSEcCtD
Pantoprazole—Agranulocytosis—Methotrexate—multiple sclerosis	0.000139	0.000508	CcSEcCtD
Pantoprazole—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000138	0.000508	CcSEcCtD
Pantoprazole—Convulsion—Betamethasone—multiple sclerosis	0.000138	0.000507	CcSEcCtD
Pantoprazole—Convulsion—Dexamethasone—multiple sclerosis	0.000138	0.000507	CcSEcCtD
Pantoprazole—Hypertension—Betamethasone—multiple sclerosis	0.000138	0.000505	CcSEcCtD
Pantoprazole—Hypertension—Dexamethasone—multiple sclerosis	0.000138	0.000505	CcSEcCtD
Pantoprazole—Asthenia—Mitoxantrone—multiple sclerosis	0.000136	0.0005	CcSEcCtD
Pantoprazole—Myalgia—Betamethasone—multiple sclerosis	0.000136	0.000498	CcSEcCtD
Pantoprazole—Myalgia—Dexamethasone—multiple sclerosis	0.000136	0.000498	CcSEcCtD
Pantoprazole—SLCO1B1—Recycling of bile acids and salts—ALB—multiple sclerosis	0.000136	0.0135	CbGpPWpGaD
Pantoprazole—Anxiety—Dexamethasone—multiple sclerosis	0.000135	0.000496	CcSEcCtD
Pantoprazole—Anxiety—Betamethasone—multiple sclerosis	0.000135	0.000496	CcSEcCtD
Pantoprazole—Discomfort—Betamethasone—multiple sclerosis	0.000134	0.000492	CcSEcCtD
Pantoprazole—Discomfort—Dexamethasone—multiple sclerosis	0.000134	0.000492	CcSEcCtD
Pantoprazole—Haemoglobin—Methotrexate—multiple sclerosis	0.000134	0.000492	CcSEcCtD
Pantoprazole—Hypotension—Methylprednisolone—multiple sclerosis	0.000134	0.000491	CcSEcCtD
Pantoprazole—Pain—Prednisolone—multiple sclerosis	0.000133	0.000489	CcSEcCtD
Pantoprazole—Hepatitis—Methotrexate—multiple sclerosis	0.000133	0.000489	CcSEcCtD
Pantoprazole—Haemorrhage—Methotrexate—multiple sclerosis	0.000133	0.000489	CcSEcCtD
Pantoprazole—Pharyngitis—Methotrexate—multiple sclerosis	0.000132	0.000485	CcSEcCtD
Pantoprazole—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000132	0.000483	CcSEcCtD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000131	0.0131	CbGpPWpGaD
Pantoprazole—Vision blurred—Prednisone—multiple sclerosis	0.000131	0.00048	CcSEcCtD
Pantoprazole—Urethral disorder—Methotrexate—multiple sclerosis	0.000131	0.000479	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000131	0.000479	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00013	0.000478	CcSEcCtD
Pantoprazole—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00013	0.000477	CcSEcCtD
Pantoprazole—Oedema—Betamethasone—multiple sclerosis	0.00013	0.000477	CcSEcCtD
Pantoprazole—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00013	0.000477	CcSEcCtD
Pantoprazole—Oedema—Dexamethasone—multiple sclerosis	0.00013	0.000477	CcSEcCtD
Pantoprazole—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00013	0.000477	CcSEcCtD
Pantoprazole—Insomnia—Triamcinolone—multiple sclerosis	0.00013	0.000476	CcSEcCtD
Pantoprazole—Insomnia—Methylprednisolone—multiple sclerosis	0.000129	0.000475	CcSEcCtD
Pantoprazole—Infection—Betamethasone—multiple sclerosis	0.000129	0.000474	CcSEcCtD
Pantoprazole—Infection—Dexamethasone—multiple sclerosis	0.000129	0.000474	CcSEcCtD
Pantoprazole—Ill-defined disorder—Prednisone—multiple sclerosis	0.000129	0.000473	CcSEcCtD
Pantoprazole—Paraesthesia—Triamcinolone—multiple sclerosis	0.000129	0.000473	CcSEcCtD
Pantoprazole—Feeling abnormal—Prednisolone—multiple sclerosis	0.000129	0.000472	CcSEcCtD
Pantoprazole—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000129	0.000471	CcSEcCtD
Pantoprazole—Visual impairment—Methotrexate—multiple sclerosis	0.000129	0.000471	CcSEcCtD
Pantoprazole—Anaemia—Prednisone—multiple sclerosis	0.000128	0.000471	CcSEcCtD
Pantoprazole—Shock—Betamethasone—multiple sclerosis	0.000128	0.00047	CcSEcCtD
Pantoprazole—Shock—Dexamethasone—multiple sclerosis	0.000128	0.00047	CcSEcCtD
Pantoprazole—Dyspnoea—Triamcinolone—multiple sclerosis	0.000128	0.000469	CcSEcCtD
Pantoprazole—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000128	0.000468	CcSEcCtD
Pantoprazole—Nervous system disorder—Betamethasone—multiple sclerosis	0.000128	0.000468	CcSEcCtD
Pantoprazole—Agitation—Prednisone—multiple sclerosis	0.000128	0.000468	CcSEcCtD
Pantoprazole—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000127	0.000467	CcSEcCtD
Pantoprazole—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000127	0.000467	CcSEcCtD
Pantoprazole—Tachycardia—Dexamethasone—multiple sclerosis	0.000127	0.000466	CcSEcCtD
Pantoprazole—Tachycardia—Betamethasone—multiple sclerosis	0.000127	0.000466	CcSEcCtD
Pantoprazole—Angioedema—Prednisone—multiple sclerosis	0.000127	0.000466	CcSEcCtD
Pantoprazole—Dyspepsia—Triamcinolone—multiple sclerosis	0.000126	0.000463	CcSEcCtD
Pantoprazole—Erythema multiforme—Methotrexate—multiple sclerosis	0.000126	0.000462	CcSEcCtD
Pantoprazole—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000126	0.000462	CcSEcCtD
Pantoprazole—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000126	0.000462	CcSEcCtD
Pantoprazole—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000126	0.000462	CcSEcCtD
Pantoprazole—Malaise—Prednisone—multiple sclerosis	0.000125	0.000459	CcSEcCtD
Pantoprazole—Vertigo—Prednisone—multiple sclerosis	0.000125	0.000458	CcSEcCtD
Pantoprazole—Eye disorder—Methotrexate—multiple sclerosis	0.000125	0.000457	CcSEcCtD
Pantoprazole—Syncope—Prednisone—multiple sclerosis	0.000125	0.000457	CcSEcCtD
Pantoprazole—Tinnitus—Methotrexate—multiple sclerosis	0.000124	0.000456	CcSEcCtD
Pantoprazole—Anorexia—Dexamethasone—multiple sclerosis	0.000124	0.000455	CcSEcCtD
Pantoprazole—Anorexia—Betamethasone—multiple sclerosis	0.000124	0.000455	CcSEcCtD
Pantoprazole—Urticaria—Prednisolone—multiple sclerosis	0.000124	0.000455	CcSEcCtD
Pantoprazole—Fatigue—Triamcinolone—multiple sclerosis	0.000124	0.000454	CcSEcCtD
Pantoprazole—Fatigue—Methylprednisolone—multiple sclerosis	0.000123	0.000453	CcSEcCtD
Pantoprazole—Pain—Triamcinolone—multiple sclerosis	0.000123	0.00045	CcSEcCtD
Pantoprazole—Loss of consciousness—Prednisone—multiple sclerosis	0.000122	0.000448	CcSEcCtD
Pantoprazole—Hypotension—Dexamethasone—multiple sclerosis	0.000122	0.000446	CcSEcCtD
Pantoprazole—Hypotension—Betamethasone—multiple sclerosis	0.000122	0.000446	CcSEcCtD
Pantoprazole—Vomiting—Mitoxantrone—multiple sclerosis	0.000121	0.000443	CcSEcCtD
Pantoprazole—Immune system disorder—Methotrexate—multiple sclerosis	0.00012	0.000442	CcSEcCtD
Pantoprazole—Convulsion—Prednisone—multiple sclerosis	0.00012	0.000441	CcSEcCtD
Pantoprazole—Hypertension—Prednisone—multiple sclerosis	0.00012	0.00044	CcSEcCtD
Pantoprazole—Rash—Mitoxantrone—multiple sclerosis	0.00012	0.00044	CcSEcCtD
Pantoprazole—Dermatitis—Mitoxantrone—multiple sclerosis	0.00012	0.000439	CcSEcCtD
Pantoprazole—Chills—Methotrexate—multiple sclerosis	0.00012	0.000439	CcSEcCtD
Pantoprazole—Headache—Mitoxantrone—multiple sclerosis	0.000119	0.000437	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000119	0.000435	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000119	0.000435	CcSEcCtD
Pantoprazole—Arthralgia—Prednisone—multiple sclerosis	0.000118	0.000434	CcSEcCtD
Pantoprazole—Myalgia—Prednisone—multiple sclerosis	0.000118	0.000434	CcSEcCtD
Pantoprazole—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000118	0.000434	CcSEcCtD
Pantoprazole—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000118	0.000433	CcSEcCtD
Pantoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000118	0.0118	CbGpPWpGaD
Pantoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000118	0.0118	CbGpPWpGaD
Pantoprazole—Anxiety—Prednisone—multiple sclerosis	0.000118	0.000432	CcSEcCtD
Pantoprazole—Alopecia—Methotrexate—multiple sclerosis	0.000118	0.000432	CcSEcCtD
Pantoprazole—Insomnia—Dexamethasone—multiple sclerosis	0.000118	0.000432	CcSEcCtD
Pantoprazole—Insomnia—Betamethasone—multiple sclerosis	0.000118	0.000432	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000117	0.000431	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000117	0.000429	CcSEcCtD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000117	0.0117	CbGpPWpGaD
Pantoprazole—Paraesthesia—Dexamethasone—multiple sclerosis	0.000117	0.000429	CcSEcCtD
Pantoprazole—Paraesthesia—Betamethasone—multiple sclerosis	0.000117	0.000429	CcSEcCtD
Pantoprazole—Discomfort—Prednisone—multiple sclerosis	0.000117	0.000429	CcSEcCtD
Pantoprazole—Mental disorder—Methotrexate—multiple sclerosis	0.000117	0.000429	CcSEcCtD
Pantoprazole—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000116	0.0116	CbGpPWpGaD
Pantoprazole—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000116	0.0116	CbGpPWpGaD
Pantoprazole—Malnutrition—Methotrexate—multiple sclerosis	0.000116	0.000426	CcSEcCtD
Pantoprazole—Hypersensitivity—Prednisolone—multiple sclerosis	0.000115	0.000422	CcSEcCtD
Pantoprazole—Dyspepsia—Dexamethasone—multiple sclerosis	0.000115	0.00042	CcSEcCtD
Pantoprazole—Dyspepsia—Betamethasone—multiple sclerosis	0.000115	0.00042	CcSEcCtD
Pantoprazole—Urticaria—Triamcinolone—multiple sclerosis	0.000114	0.000418	CcSEcCtD
Pantoprazole—Urticaria—Methylprednisolone—multiple sclerosis	0.000114	0.000417	CcSEcCtD
Pantoprazole—Dysgeusia—Methotrexate—multiple sclerosis	0.000114	0.000417	CcSEcCtD
Pantoprazole—Body temperature increased—Triamcinolone—multiple sclerosis	0.000113	0.000416	CcSEcCtD
Pantoprazole—Anaphylactic shock—Prednisone—multiple sclerosis	0.000113	0.000416	CcSEcCtD
Pantoprazole—Oedema—Prednisone—multiple sclerosis	0.000113	0.000416	CcSEcCtD
Pantoprazole—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000113	0.000415	CcSEcCtD
Pantoprazole—Decreased appetite—Betamethasone—multiple sclerosis	0.000113	0.000415	CcSEcCtD
Pantoprazole—Decreased appetite—Dexamethasone—multiple sclerosis	0.000113	0.000415	CcSEcCtD
Pantoprazole—Nausea—Mitoxantrone—multiple sclerosis	0.000113	0.000414	CcSEcCtD
Pantoprazole—Infection—Prednisone—multiple sclerosis	0.000113	0.000413	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000112	0.000412	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000112	0.000412	CcSEcCtD
Pantoprazole—Back pain—Methotrexate—multiple sclerosis	0.000112	0.000412	CcSEcCtD
Pantoprazole—Fatigue—Dexamethasone—multiple sclerosis	0.000112	0.000412	CcSEcCtD
Pantoprazole—Fatigue—Betamethasone—multiple sclerosis	0.000112	0.000412	CcSEcCtD
Pantoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000112	0.0111	CbGpPWpGaD
Pantoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000112	0.0111	CbGpPWpGaD
Pantoprazole—Shock—Prednisone—multiple sclerosis	0.000112	0.000409	CcSEcCtD
Pantoprazole—Pain—Betamethasone—multiple sclerosis	0.000111	0.000408	CcSEcCtD
Pantoprazole—Pain—Dexamethasone—multiple sclerosis	0.000111	0.000408	CcSEcCtD
Pantoprazole—Nervous system disorder—Prednisone—multiple sclerosis	0.000111	0.000408	CcSEcCtD
Pantoprazole—Tachycardia—Prednisone—multiple sclerosis	0.000111	0.000406	CcSEcCtD
Pantoprazole—Skin disorder—Prednisone—multiple sclerosis	0.00011	0.000404	CcSEcCtD
Pantoprazole—Hyperhidrosis—Prednisone—multiple sclerosis	0.00011	0.000402	CcSEcCtD
Pantoprazole—Vision blurred—Methotrexate—multiple sclerosis	0.000109	0.000401	CcSEcCtD
Pantoprazole—Anorexia—Prednisone—multiple sclerosis	0.000108	0.000396	CcSEcCtD
Pantoprazole—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000108	0.000395	CcSEcCtD
Pantoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000108	0.0107	CbGpPWpGaD
Pantoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000108	0.0107	CbGpPWpGaD
Pantoprazole—Anaemia—Methotrexate—multiple sclerosis	0.000107	0.000394	CcSEcCtD
Pantoprazole—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000107	0.000393	CcSEcCtD
Pantoprazole—Feeling abnormal—Betamethasone—multiple sclerosis	0.000107	0.000393	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000106	0.00039	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000106	0.00039	CcSEcCtD
Pantoprazole—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000106	0.0106	CbGpPWpGaD
Pantoprazole—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000106	0.0106	CbGpPWpGaD
Pantoprazole—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000106	0.000388	CcSEcCtD
Pantoprazole—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000105	0.000387	CcSEcCtD
Pantoprazole—Malaise—Methotrexate—multiple sclerosis	0.000105	0.000384	CcSEcCtD
Pantoprazole—Vertigo—Methotrexate—multiple sclerosis	0.000104	0.000383	CcSEcCtD
Pantoprazole—Leukopenia—Methotrexate—multiple sclerosis	0.000104	0.000381	CcSEcCtD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000104	0.0103	CbGpPWpGaD
Pantoprazole—Urticaria—Dexamethasone—multiple sclerosis	0.000103	0.000379	CcSEcCtD
Pantoprazole—Urticaria—Betamethasone—multiple sclerosis	0.000103	0.000379	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000103	0.000379	CcSEcCtD
Pantoprazole—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000103	0.0103	CbGpPWpGaD
Pantoprazole—Dizziness—Prednisolone—multiple sclerosis	0.000103	0.000378	CcSEcCtD
Pantoprazole—Asthenia—Triamcinolone—multiple sclerosis	0.000103	0.000378	CcSEcCtD
Pantoprazole—Abdominal pain—Dexamethasone—multiple sclerosis	0.000103	0.000377	CcSEcCtD
Pantoprazole—Body temperature increased—Dexamethasone—multiple sclerosis	0.000103	0.000377	CcSEcCtD
Pantoprazole—Abdominal pain—Betamethasone—multiple sclerosis	0.000103	0.000377	CcSEcCtD
Pantoprazole—Body temperature increased—Betamethasone—multiple sclerosis	0.000103	0.000377	CcSEcCtD
Pantoprazole—Asthenia—Methylprednisolone—multiple sclerosis	0.000103	0.000377	CcSEcCtD
Pantoprazole—Insomnia—Prednisone—multiple sclerosis	0.000103	0.000376	CcSEcCtD
Pantoprazole—Paraesthesia—Prednisone—multiple sclerosis	0.000102	0.000373	CcSEcCtD
Pantoprazole—Pruritus—Triamcinolone—multiple sclerosis	0.000101	0.000372	CcSEcCtD
Pantoprazole—Cough—Methotrexate—multiple sclerosis	0.000101	0.000372	CcSEcCtD
Pantoprazole—Pruritus—Methylprednisolone—multiple sclerosis	0.000101	0.000371	CcSEcCtD
Pantoprazole—Convulsion—Methotrexate—multiple sclerosis	0.000101	0.000369	CcSEcCtD
Pantoprazole—Dyspepsia—Prednisone—multiple sclerosis	9.98e-05	0.000366	CcSEcCtD
Pantoprazole—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	9.89e-05	0.00986	CbGpPWpGaD
Pantoprazole—Arthralgia—Methotrexate—multiple sclerosis	9.88e-05	0.000363	CcSEcCtD
Pantoprazole—Chest pain—Methotrexate—multiple sclerosis	9.88e-05	0.000363	CcSEcCtD
Pantoprazole—Myalgia—Methotrexate—multiple sclerosis	9.88e-05	0.000363	CcSEcCtD
Pantoprazole—Decreased appetite—Prednisone—multiple sclerosis	9.85e-05	0.000361	CcSEcCtD
Pantoprazole—Rash—Prednisolone—multiple sclerosis	9.84e-05	0.000361	CcSEcCtD
Pantoprazole—Dermatitis—Prednisolone—multiple sclerosis	9.83e-05	0.00036	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	9.81e-05	0.00036	CcSEcCtD
Pantoprazole—Diarrhoea—Methylprednisolone—multiple sclerosis	9.79e-05	0.000359	CcSEcCtD
Pantoprazole—Fatigue—Prednisone—multiple sclerosis	9.77e-05	0.000358	CcSEcCtD
Pantoprazole—Headache—Prednisolone—multiple sclerosis	9.77e-05	0.000358	CcSEcCtD
Pantoprazole—Discomfort—Methotrexate—multiple sclerosis	9.76e-05	0.000358	CcSEcCtD
Pantoprazole—Constipation—Prednisone—multiple sclerosis	9.69e-05	0.000356	CcSEcCtD
Pantoprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	9.56e-05	0.00953	CbGpPWpGaD
Pantoprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	9.56e-05	0.00953	CbGpPWpGaD
Pantoprazole—Confusional state—Methotrexate—multiple sclerosis	9.55e-05	0.00035	CcSEcCtD
Pantoprazole—Dizziness—Triamcinolone—multiple sclerosis	9.49e-05	0.000348	CcSEcCtD
Pantoprazole—Anaphylactic shock—Methotrexate—multiple sclerosis	9.47e-05	0.000348	CcSEcCtD
Pantoprazole—Dizziness—Methylprednisolone—multiple sclerosis	9.47e-05	0.000347	CcSEcCtD
Pantoprazole—Infection—Methotrexate—multiple sclerosis	9.41e-05	0.000345	CcSEcCtD
Pantoprazole—Feeling abnormal—Prednisone—multiple sclerosis	9.34e-05	0.000343	CcSEcCtD
Pantoprazole—Asthenia—Dexamethasone—multiple sclerosis	9.34e-05	0.000343	CcSEcCtD
Pantoprazole—Asthenia—Betamethasone—multiple sclerosis	9.34e-05	0.000343	CcSEcCtD
Pantoprazole—Nervous system disorder—Methotrexate—multiple sclerosis	9.29e-05	0.000341	CcSEcCtD
Pantoprazole—Thrombocytopenia—Methotrexate—multiple sclerosis	9.28e-05	0.00034	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Prednisone—multiple sclerosis	9.27e-05	0.00034	CcSEcCtD
Pantoprazole—Nausea—Prednisolone—multiple sclerosis	9.27e-05	0.00034	CcSEcCtD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.24e-05	0.00921	CbGpPWpGaD
Pantoprazole—Pruritus—Dexamethasone—multiple sclerosis	9.21e-05	0.000338	CcSEcCtD
Pantoprazole—Pruritus—Betamethasone—multiple sclerosis	9.21e-05	0.000338	CcSEcCtD
Pantoprazole—Skin disorder—Methotrexate—multiple sclerosis	9.2e-05	0.000338	CcSEcCtD
Pantoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	9.19e-05	0.00916	CbGpPWpGaD
Pantoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	9.19e-05	0.00916	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.17e-05	0.00914	CbGpPWpGaD
Pantoprazole—Hyperhidrosis—Methotrexate—multiple sclerosis	9.16e-05	0.000336	CcSEcCtD
Pantoprazole—Vomiting—Triamcinolone—multiple sclerosis	9.12e-05	0.000335	CcSEcCtD
Pantoprazole—Vomiting—Methylprednisolone—multiple sclerosis	9.1e-05	0.000334	CcSEcCtD
Pantoprazole—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	9.07e-05	0.00904	CbGpPWpGaD
Pantoprazole—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	9.07e-05	0.00904	CbGpPWpGaD
Pantoprazole—Rash—Triamcinolone—multiple sclerosis	9.05e-05	0.000332	CcSEcCtD
Pantoprazole—Dermatitis—Triamcinolone—multiple sclerosis	9.04e-05	0.000331	CcSEcCtD
Pantoprazole—Anorexia—Methotrexate—multiple sclerosis	9.03e-05	0.000331	CcSEcCtD
Pantoprazole—Rash—Methylprednisolone—multiple sclerosis	9.03e-05	0.000331	CcSEcCtD
Pantoprazole—Dermatitis—Methylprednisolone—multiple sclerosis	9.02e-05	0.000331	CcSEcCtD
Pantoprazole—Urticaria—Prednisone—multiple sclerosis	9.01e-05	0.00033	CcSEcCtD
Pantoprazole—Headache—Triamcinolone—multiple sclerosis	8.99e-05	0.00033	CcSEcCtD
Pantoprazole—Headache—Methylprednisolone—multiple sclerosis	8.97e-05	0.000329	CcSEcCtD
Pantoprazole—Abdominal pain—Prednisone—multiple sclerosis	8.96e-05	0.000329	CcSEcCtD
Pantoprazole—Body temperature increased—Prednisone—multiple sclerosis	8.96e-05	0.000329	CcSEcCtD
Pantoprazole—Diarrhoea—Betamethasone—multiple sclerosis	8.91e-05	0.000327	CcSEcCtD
Pantoprazole—Diarrhoea—Dexamethasone—multiple sclerosis	8.91e-05	0.000327	CcSEcCtD
Pantoprazole—Hypotension—Methotrexate—multiple sclerosis	8.85e-05	0.000325	CcSEcCtD
Pantoprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	8.72e-05	0.00869	CbGpPWpGaD
Pantoprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	8.72e-05	0.00869	CbGpPWpGaD
Pantoprazole—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	8.63e-05	0.000317	CcSEcCtD
Pantoprazole—Dizziness—Dexamethasone—multiple sclerosis	8.61e-05	0.000316	CcSEcCtD
Pantoprazole—Dizziness—Betamethasone—multiple sclerosis	8.61e-05	0.000316	CcSEcCtD
Pantoprazole—Insomnia—Methotrexate—multiple sclerosis	8.57e-05	0.000314	CcSEcCtD
Pantoprazole—Nausea—Triamcinolone—multiple sclerosis	8.52e-05	0.000313	CcSEcCtD
Pantoprazole—Paraesthesia—Methotrexate—multiple sclerosis	8.51e-05	0.000312	CcSEcCtD
Pantoprazole—Nausea—Methylprednisolone—multiple sclerosis	8.5e-05	0.000312	CcSEcCtD
Pantoprazole—Dyspnoea—Methotrexate—multiple sclerosis	8.45e-05	0.00031	CcSEcCtD
Pantoprazole—Somnolence—Methotrexate—multiple sclerosis	8.42e-05	0.000309	CcSEcCtD
Pantoprazole—Hypersensitivity—Prednisone—multiple sclerosis	8.35e-05	0.000306	CcSEcCtD
Pantoprazole—Dyspepsia—Methotrexate—multiple sclerosis	8.34e-05	0.000306	CcSEcCtD
Pantoprazole—Vomiting—Dexamethasone—multiple sclerosis	8.28e-05	0.000304	CcSEcCtD
Pantoprazole—Vomiting—Betamethasone—multiple sclerosis	8.28e-05	0.000304	CcSEcCtD
Pantoprazole—Decreased appetite—Methotrexate—multiple sclerosis	8.24e-05	0.000302	CcSEcCtD
Pantoprazole—Rash—Dexamethasone—multiple sclerosis	8.21e-05	0.000301	CcSEcCtD
Pantoprazole—Rash—Betamethasone—multiple sclerosis	8.21e-05	0.000301	CcSEcCtD
Pantoprazole—Dermatitis—Dexamethasone—multiple sclerosis	8.2e-05	0.000301	CcSEcCtD
Pantoprazole—Dermatitis—Betamethasone—multiple sclerosis	8.2e-05	0.000301	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Methotrexate—multiple sclerosis	8.18e-05	0.0003	CcSEcCtD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.17e-05	0.00815	CbGpPWpGaD
Pantoprazole—Fatigue—Methotrexate—multiple sclerosis	8.17e-05	0.0003	CcSEcCtD
Pantoprazole—Headache—Betamethasone—multiple sclerosis	8.15e-05	0.000299	CcSEcCtD
Pantoprazole—Headache—Dexamethasone—multiple sclerosis	8.15e-05	0.000299	CcSEcCtD
Pantoprazole—Asthenia—Prednisone—multiple sclerosis	8.13e-05	0.000298	CcSEcCtD
Pantoprazole—Pain—Methotrexate—multiple sclerosis	8.1e-05	0.000297	CcSEcCtD
Pantoprazole—Pruritus—Prednisone—multiple sclerosis	8.02e-05	0.000294	CcSEcCtD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	7.88e-05	0.00785	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—C4A—multiple sclerosis	7.85e-05	0.00783	CbGpPWpGaD
Pantoprazole—Feeling abnormal—Methotrexate—multiple sclerosis	7.81e-05	0.000286	CcSEcCtD
Pantoprazole—Diarrhoea—Prednisone—multiple sclerosis	7.76e-05	0.000285	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.75e-05	0.000284	CcSEcCtD
Pantoprazole—Nausea—Betamethasone—multiple sclerosis	7.73e-05	0.000284	CcSEcCtD
Pantoprazole—Nausea—Dexamethasone—multiple sclerosis	7.73e-05	0.000284	CcSEcCtD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	7.65e-05	0.00763	CbGpPWpGaD
Pantoprazole—Urticaria—Methotrexate—multiple sclerosis	7.53e-05	0.000276	CcSEcCtD
Pantoprazole—Dizziness—Prednisone—multiple sclerosis	7.5e-05	0.000275	CcSEcCtD
Pantoprazole—Body temperature increased—Methotrexate—multiple sclerosis	7.49e-05	0.000275	CcSEcCtD
Pantoprazole—Abdominal pain—Methotrexate—multiple sclerosis	7.49e-05	0.000275	CcSEcCtD
Pantoprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	7.45e-05	0.00743	CbGpPWpGaD
Pantoprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	7.45e-05	0.00743	CbGpPWpGaD
Pantoprazole—Vomiting—Prednisone—multiple sclerosis	7.21e-05	0.000264	CcSEcCtD
Pantoprazole—Rash—Prednisone—multiple sclerosis	7.15e-05	0.000262	CcSEcCtD
Pantoprazole—Dermatitis—Prednisone—multiple sclerosis	7.14e-05	0.000262	CcSEcCtD
Pantoprazole—Headache—Prednisone—multiple sclerosis	7.1e-05	0.00026	CcSEcCtD
Pantoprazole—SLCO1B1—Bile acid and bile salt metabolism—ALB—multiple sclerosis	7.1e-05	0.00707	CbGpPWpGaD
Pantoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	7.09e-05	0.00707	CbGpPWpGaD
Pantoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	7.09e-05	0.00707	CbGpPWpGaD
Pantoprazole—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	7e-05	0.00698	CbGpPWpGaD
Pantoprazole—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	7e-05	0.00698	CbGpPWpGaD
Pantoprazole—Hypersensitivity—Methotrexate—multiple sclerosis	6.98e-05	0.000256	CcSEcCtD
Pantoprazole—Asthenia—Methotrexate—multiple sclerosis	6.8e-05	0.000249	CcSEcCtD
Pantoprazole—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	6.8e-05	0.00678	CbGpPWpGaD
Pantoprazole—Nausea—Prednisone—multiple sclerosis	6.73e-05	0.000247	CcSEcCtD
Pantoprazole—Pruritus—Methotrexate—multiple sclerosis	6.7e-05	0.000246	CcSEcCtD
Pantoprazole—Diarrhoea—Methotrexate—multiple sclerosis	6.48e-05	0.000238	CcSEcCtD
Pantoprazole—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	6.4e-05	0.00638	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	6.4e-05	0.00638	CbGpPWpGaD
Pantoprazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	6.36e-05	0.00634	CbGpPWpGaD
Pantoprazole—Dizziness—Methotrexate—multiple sclerosis	6.26e-05	0.00023	CcSEcCtD
Pantoprazole—Vomiting—Methotrexate—multiple sclerosis	6.02e-05	0.000221	CcSEcCtD
Pantoprazole—Rash—Methotrexate—multiple sclerosis	5.97e-05	0.000219	CcSEcCtD
Pantoprazole—Dermatitis—Methotrexate—multiple sclerosis	5.97e-05	0.000219	CcSEcCtD
Pantoprazole—Headache—Methotrexate—multiple sclerosis	5.94e-05	0.000218	CcSEcCtD
Pantoprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.93e-05	0.00591	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	5.82e-05	0.00581	CbGpPWpGaD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	5.8e-05	0.00578	CbGpPWpGaD
Pantoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	5.75e-05	0.00573	CbGpPWpGaD
Pantoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	5.75e-05	0.00573	CbGpPWpGaD
Pantoprazole—Nausea—Methotrexate—multiple sclerosis	5.63e-05	0.000206	CcSEcCtD
Pantoprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.54e-05	0.00553	CbGpPWpGaD
Pantoprazole—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	5.52e-05	0.00551	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	5.49e-05	0.00548	CbGpPWpGaD
Pantoprazole—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	5.08e-05	0.00506	CbGpPWpGaD
Pantoprazole—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	5.08e-05	0.00506	CbGpPWpGaD
Pantoprazole—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	5.01e-05	0.00499	CbGpPWpGaD
Pantoprazole—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	5.01e-05	0.00499	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	4.99e-05	0.00497	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	4.95e-05	0.00493	CbGpPWpGaD
Pantoprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	4.74e-05	0.00472	CbGpPWpGaD
Pantoprazole—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	4.63e-05	0.00462	CbGpPWpGaD
Pantoprazole—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	4.63e-05	0.00462	CbGpPWpGaD
Pantoprazole—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.57e-05	0.00455	CbGpPWpGaD
Pantoprazole—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.57e-05	0.00455	CbGpPWpGaD
Pantoprazole—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	4.37e-05	0.00436	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	4.32e-05	0.00431	CbGpPWpGaD
Pantoprazole—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	4.3e-05	0.00429	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—CD28—multiple sclerosis	4.2e-05	0.00419	CbGpPWpGaD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	4.05e-05	0.00404	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	4.02e-05	0.00401	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	3.99e-05	0.00398	CbGpPWpGaD
Pantoprazole—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	3.96e-05	0.00395	CbGpPWpGaD
Pantoprazole—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	3.96e-05	0.00395	CbGpPWpGaD
Pantoprazole—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.9e-05	0.00389	CbGpPWpGaD
Pantoprazole—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.9e-05	0.00389	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.89e-05	0.00388	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—CD40—multiple sclerosis	3.84e-05	0.00382	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.8e-05	0.00379	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.8e-05	0.00379	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	3.78e-05	0.00377	CbGpPWpGaD
Pantoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	3.65e-05	0.00364	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.6e-05	0.00359	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	3.45e-05	0.00344	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	3.33e-05	0.00332	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.3e-05	0.00329	CbGpPWpGaD
Pantoprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.26e-05	0.00325	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	3.11e-05	0.0031	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	3.05e-05	0.00304	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	3.05e-05	0.00304	CbGpPWpGaD
Pantoprazole—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.01e-05	0.003	CbGpPWpGaD
Pantoprazole—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.01e-05	0.003	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—CD86—multiple sclerosis	3e-05	0.00299	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.95e-05	0.00294	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.94e-05	0.00293	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL10—multiple sclerosis	2.94e-05	0.00293	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	2.94e-05	0.00293	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL4—multiple sclerosis	2.86e-05	0.00285	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	2.8e-05	0.00279	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.73e-05	0.00272	CbGpPWpGaD
Pantoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.65e-05	0.00264	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—FAS—multiple sclerosis	2.64e-05	0.00263	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	2.62e-05	0.00261	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	2.59e-05	0.00258	CbGpPWpGaD
Pantoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.42e-05	0.00241	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—SRM—multiple sclerosis	2.4e-05	0.0024	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	2.37e-05	0.00236	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.33e-05	0.00232	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—SRM—multiple sclerosis	2.23e-05	0.00222	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—CD80—multiple sclerosis	2.19e-05	0.00218	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.16e-05	0.00215	CbGpPWpGaD
Pantoprazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.15e-05	0.00214	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	2.13e-05	0.00212	CbGpPWpGaD
Pantoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.07e-05	0.00206	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.06e-05	0.00205	CbGpPWpGaD
Pantoprazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.96e-05	0.00196	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.95e-05	0.00194	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.95e-05	0.00194	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.95e-05	0.00194	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.91e-05	0.0019	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	1.9e-05	0.00189	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	1.89e-05	0.00189	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	1.89e-05	0.00188	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.78e-05	0.00177	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.78e-05	0.00177	CbGpPWpGaD
Pantoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	1.76e-05	0.00175	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	1.73e-05	0.00172	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	1.69e-05	0.00169	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	1.69e-05	0.00169	CbGpPWpGaD
Pantoprazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.68e-05	0.00167	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.65e-05	0.00165	CbGpPWpGaD
Pantoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.6e-05	0.00159	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP27B1—multiple sclerosis	1.57e-05	0.00156	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP24A1—multiple sclerosis	1.57e-05	0.00156	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GPC5—multiple sclerosis	1.55e-05	0.00154	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1.54e-05	0.00154	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL2—multiple sclerosis	1.54e-05	0.00153	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.52e-05	0.00152	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.52e-05	0.00151	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.52e-05	0.00151	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	1.48e-05	0.00147	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.48e-05	0.00147	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	1.47e-05	0.00147	CbGpPWpGaD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.46e-05	0.00145	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	1.45e-05	0.00144	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GPC5—multiple sclerosis	1.43e-05	0.00143	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	1.38e-05	0.00137	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	1.38e-05	0.00137	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.3e-05	0.0013	CbGpPWpGaD
Pantoprazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.29e-05	0.00129	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—RRM1—multiple sclerosis	1.28e-05	0.00128	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SRM—multiple sclerosis	1.23e-05	0.00123	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SRM—multiple sclerosis	1.2e-05	0.0012	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.2e-05	0.00119	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—RRM1—multiple sclerosis	1.19e-05	0.00118	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.17e-05	0.00116	CbGpPWpGaD
Pantoprazole—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.14e-05	0.00114	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SRM—multiple sclerosis	1.12e-05	0.00112	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.12e-05	0.00112	CbGpPWpGaD
Pantoprazole—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.04e-05	0.00104	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.03e-05	0.00103	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.96e-06	0.000993	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SRM—multiple sclerosis	9.6e-06	0.000958	CbGpPWpGaD
Pantoprazole—CYP1A2—Biological oxidations—POMC—multiple sclerosis	8.9e-06	0.000887	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	8.68e-06	0.000866	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	8.68e-06	0.000866	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.55e-06	0.000853	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.49e-06	0.000846	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP27B1—multiple sclerosis	8.48e-06	0.000845	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP24A1—multiple sclerosis	8.48e-06	0.000845	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GPC5—multiple sclerosis	7.94e-06	0.000792	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	7.92e-06	0.00079	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	7.92e-06	0.00079	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.8e-06	0.000777	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GPC5—multiple sclerosis	7.75e-06	0.000773	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.74e-06	0.000772	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.41e-06	0.000739	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SRM—multiple sclerosis	7.41e-06	0.000739	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—BCHE—multiple sclerosis	7.37e-06	0.000735	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GPC5—multiple sclerosis	7.24e-06	0.000722	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—POMC—multiple sclerosis	6.87e-06	0.000685	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.86e-06	0.000684	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—BCHE—multiple sclerosis	6.82e-06	0.00068	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	6.77e-06	0.000675	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	6.77e-06	0.000675	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.61e-06	0.000659	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—RRM1—multiple sclerosis	6.58e-06	0.000656	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—RRM1—multiple sclerosis	6.42e-06	0.00064	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GPC5—multiple sclerosis	6.19e-06	0.000617	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—RRM1—multiple sclerosis	6e-06	0.000598	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.93e-06	0.000591	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.91e-06	0.00059	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.8e-06	0.000578	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.52e-06	0.00055	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	5.22e-06	0.000521	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	5.22e-06	0.000521	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—RRM1—multiple sclerosis	5.13e-06	0.000511	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.11e-06	0.000509	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.78e-06	0.000476	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.66e-06	0.000464	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—APOE—multiple sclerosis	4.43e-06	0.000442	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.39e-06	0.000437	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—APOE—multiple sclerosis	4.11e-06	0.000409	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4e-06	0.000399	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4e-06	0.000399	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.98e-06	0.000397	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.96e-06	0.000395	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—POMC—multiple sclerosis	3.81e-06	0.00038	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—BCHE—multiple sclerosis	3.78e-06	0.000377	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.71e-06	0.00037	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—BCHE—multiple sclerosis	3.69e-06	0.000368	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.65e-06	0.000364	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—POMC—multiple sclerosis	3.53e-06	0.000352	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ALB—multiple sclerosis	3.47e-06	0.000346	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—BCHE—multiple sclerosis	3.45e-06	0.000344	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.42e-06	0.000341	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ALB—multiple sclerosis	3.22e-06	0.000321	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.12e-06	0.000311	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.95e-06	0.000294	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—APOE—multiple sclerosis	2.27e-06	0.000227	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.27e-06	0.000227	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—APOE—multiple sclerosis	2.22e-06	0.000221	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—APOE—multiple sclerosis	2.07e-06	0.000207	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—POMC—multiple sclerosis	1.95e-06	0.000195	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—POMC—multiple sclerosis	1.91e-06	0.00019	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—POMC—multiple sclerosis	1.78e-06	0.000178	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALB—multiple sclerosis	1.78e-06	0.000178	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—APOE—multiple sclerosis	1.77e-06	0.000177	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALB—multiple sclerosis	1.74e-06	0.000173	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALB—multiple sclerosis	1.62e-06	0.000162	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—POMC—multiple sclerosis	1.52e-06	0.000152	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALB—multiple sclerosis	1.39e-06	0.000138	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—APOE—multiple sclerosis	1.37e-06	0.000136	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—POMC—multiple sclerosis	1.17e-06	0.000117	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALB—multiple sclerosis	1.07e-06	0.000107	CbGpPWpGaD
